Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/30/2021 11 1
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Hemin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/13/2021 1 1
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/04/2021 3 0
Curcumin Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021 6 0